Christopher Tsoi

Christopher Tsoi is currently serving as Senior Director of Finance at Anomali since January 2023. Prior to this role, Christopher held various finance positions at companies including Arkose Labs, Yext, Artsy, Aimmune Therapeutics, E2open, and Moelis & Company, where Christopher gained extensive experience in financial planning, analysis, and strategic finance. Christopher's educational background includes a Bachelor of Business Administration (BBA) in Finance from the University of Michigan's Stephen M. Ross School of Business and participation in an intensive seminar on drug development at UC Berkeley Extension.